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Contribution of phosphatidic acid (PA) generated by activated phosphohpase (PL) D to PLAz activation was studied m rat peritoneal mast cells. 
Exogenous didecanoyl PA induced arachidonate hberation in the permeabilized cells which was inhibited by p-bromophenacyl bromide. Upon 
exposure of the cells to ethanol in a high enough concentration to prevent PA formation. A23187-induced arachidonate hberdtion was suppressed 
by 50% and the rest was completely mhtbited by p-bromophenacyl bromide. In contrast, propranolol, which enhanced PA accumulation, 
significantly increased the arachidonate liberation. These results suggest that A23187-Induced PLAz activation may be potentiated, at least m part, 
by PA generated through PLD action. 
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1. INTRODUCTION 
Evidence has recently accumulated showing that 
phosphatidic acid (PA) which is formed by phospholip- 
ase (PL) D-catalyzed hydrolysis of phosphatidylcholine 
is implicated in the sequence of stimulus-response cou- 
pling in various types of cells. This idea has been devel- 
oped by many observations showing that exogenously 
added PA or fungal PLD to generate PA mimics phys- 
iological agonists causing various kinds of cellular re- 
sponses: neurotransmitter [l] or hormone release [2,3], 
enzyme activation such as PLC [4-lo], protein kinases 
[l l-l 31 and phosphatidylinositol-4-phosphate kinase 
[14]. and cell proliferation via promoting DNA synthe- 
sis [4,15-181 or increasing Ras activity by inhibiting the 
GTPase activating protein and stimulating the GTPase 
inhibiting protein [19,20]. Recently we have reported 
that exogenous PA stimulates PLA, and PLC activity, 
most notably potentiating PLA, activity in its low con- 
centrations in rabbit platelets [21,22]. This suggests that 
PA generated under physiological stimuli, at least in 
part, may contribute to enhance preferentially the acti- 
vation of PLA,. However, it is not yet clear if en- 
dogenous PA plays such a role in the sequence of stim- 
ulus-response coupling in agonist-stimulated cells. 
In this work, therefore, we examined whether or not 
endogenously generated PA by activated PLD can po- 
tentiate PLA, activation in rat peritoneal mast cells in 
response to A23187. since it is reported that the mast 
cells have a substantial PLD activity [23-251 and also 
that A23187 can activate PLA, in the cells [26]. 
2. MATERIALS AND METHODS 
2.1. Mutwials 
Didecanoyl PA was preparated from didecanoyl-phosphati- 
dylcholine (Sigma. St. Louis, MO, USA) by the hydrolytic action of 
PLD from Streptom.wes chromofuscus (Boehringer Mannhetm. Ger- 
many) and purified by thm layer chromatography developed in chlo- 
roform/methanol/acetic acid/water (60:30:8:4, by vol.) [21]. We con- 
firmed that the didecanoyl PA did not contam the corresponding 
lysodecanoyl PA. Propranolol and p-bromophenacyl bromide were 
obtained from Wako Pure Chemical Industries (Osaka, Japan). Bo- 
vine serum albunin (BSA, fractionv) was from Sigma Chemical Co. 
(St. Louis, MO, USA). A23187 was from Calbiochem (La Jolla. CA, 
USA). [‘H]Arachidomc acid ([‘H]AA. 76.0 Cilmmol) was from New 
England Nuclear (Boston, MA. USA). Phosphatidylethanol used as 
a standard was prepared according to the method of Comfurius and 
Zwaal [27]. Other reagents were obtained from commercial sources. 
2.2. Preparution of rat peritoneul mast cells and [‘H]AA labeling 
Mast cells were harvested from peritoneal fluid taken from male 
Wistar rats of 8 weeks of age. The cells were purified as described 
previously [28]. Briefly, the peritoneal cells suspended in a medium, 
composed of 150 mM NaCl. 3.7 mM KCl, 3 mM Na?HPO,, 3.5 mM 
KH?PO,. 6 mM glucose. 1 mg/ml BSA, 1 mg/ml gelatm and 10 U/ml 
heparin (pH 6.8). were centrifuged at 50 x g for 6 min at 4°C. and then 
the pellet was suspended in the medium. The suspension was layered 
over a 31.5% BSA-sahne solution, followed by centrifugation at 
300 x g for 10 mm at 4°C. The pellet was washed twice and then the 
cells were resuspended at 5 x 10’ cells/ml in the medium. The purified 
mast cells were Incubated with [‘H]AA (lO@lml) at 37°C for 2 h and 
then washed twice. The cell number was adjusted to 5 x lo5 cells/ml 
in the same medium without heparin. 
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2 3. Meusurement of hpid n~etabolisnz 
[3H]AA-labeled mast cells or the cells permeabllized with 15 ,&ml 
saponin [28] were incubated with BW755C (80 PM: 3-amino-[m- 
(trifluoromethyl)-phenyll-2-pyrazoline, a lipoxygenase and cycloxyge- 
nase inhibitor) [29] at 37°C for 2 min, and subjected to various exper- 
iments After the reaction was terminated by the addition of ice-cold 
chloroformlmethanol/HCl (200 200 : 1, by vol.), hpids were ex- 
tracted and separated by thin layer chromatography on a Silica Gel 
G plate (Merck) with a developing solvent system of petroleum ether/ 
dlethyl ether/acetic acid (SO : 80 : 1.5, by vol.) or the combination of 
chloroform/methanol/7 M NH,OH (60 : 45 : 7.3, by vol ) in the first 
dimension, and chlorofom/methanol/acetlc acid/water 160 : 30 : 8 : 4, 
by vol.) m the second dimension. Each fatty acid, PA and phosphati- 
dylethanol fraction. identified on the basis of comigratlon with au- 
thentic standards was scraped off and the radloactlvity was deter- 
mined by liquid scmtlllatlon counting. 
3. RESULTS 
3.1. Didecanoyl PA-induced PLA? activatiorz 
To confirm whether or not PA can activate PLAl in 
mast cells, we examined the effect of exogenous addition 
of didecanoyl PA to mast cells on PLA, activation. In 
this experiment we used saponin-permeabilized mast 
cells to exclude the Ca’+ ionophoretic effect of the PA 
[30], since these permeabilized cells are not influenced 
by Ca2’ permeation through membranes. Fig. 1A shows 
that an addition of didecanoyl PA to [3H]AA-labeled 
mast cells liberated dose-dependently [3H]AA in the 
presence of Ca’+. Didecanoyl PA also induced dose- 
dependent [3H]AA liberation from [3H]AA-labeled in- 
tact mast cells in the presence of Ca7+ (data not shown). 
Furthermore, as seen in Fig. IB, the didecanoyl PA- 
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Fig. 1. Didecanoyl PA-induced AA liberation (A) and the inhibItion 
by p-bromophenacyl bromide (BPB) (B). Various concentrations of 
didecanoyl PA (C,,PA) were added to [‘H]AA-labeled. saponin-per- 
meabilized mast cells m the presence of 50 PM CaCl, (0) or 1 mM 
EGTA Q_,) and the mixture was incubated at 37°C for 10 min (A) 
[‘H]AA-labeled, sapomn-permeabked mast cells were treated with 
various concentrations of BPB at 37°C for 10 min and then 60 PM 
C,,PA (0) or buffer (,-,) was added and mcubated in the presence of 
SOpM CaClz as above (B). The radioactivity of [‘H]AA liberated was 
determined. Each point represents mean + S.E M. of three separate 
experiments. 
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Fig. 2. Effect of ethanol (A) or propranolol (B) on A23187-mduced 
PA formation and AA hberatlon. [‘HIAA-labeled mast cells were 
treated with various concentrations of ethanol (A) or propranolol (B) 
at 37°C for 10 mm. and then stimulated with 30 nM A?3187 (0,~) or 
DMSO (s- .I) m the presence of 1.3 mM CaClz for additional 10 min. 
The radioactlvity of [‘HIPA (0. ) or [‘H]AA (A.. ) was determined. 
Each point represents mean + S E.M. of three separate experiments. 
*,**Significantly different from the correspondmg values without pro- 
pranolol (P < 0 05 and P < 0.02. respectively). 
induced AA liberation was inhibited by p-bromophena- 
cyl bromide. a PLAz inhibitor. These results indicate 
that PA can activate PLA,. 
3.2. A23187-induced uctivation of PLD 
A23187. a Ca” ionophore, is reported to stimulate 
endogenous PLD activity to form PA and 1,2-dia- 
cylglycerol (DAG) in many cell types [31-341. There- 
fore, we examined A23187-induced PLD activation in 
mast cells. As shown in Fig. 2A. when [“H]AA-labeled 
mast cells were exposed to A23187 in the presence of 
various concentrations of ethanol, [‘HIPA formed by 
the stimulation was decreased in a dose-dependent man- 
ner and at 3% ethanol the PA formation was almost 
completely inhibited. In contrast, [3H]phosphatidyl- 
ethanol that was formed by the PLD-catalyzed 
transphosphatidylation reaction increased as a function 
of the ethanol concentration (128 4 10 dpm at O%, 
2.912 + 349 dpm at l%, and 5,876 _+ 717 dpm at 2% of 
ethanol, the mean t S.E. (~2 = 3)). These observations 
indicate that stimulation with A23187 activates PLD in 
mast cells. 
3.3. Contribution of PLD-derived PA to PLA, activation 
Since exogenously added PA could activate PLA, 
(Fig. l), we further studied the effect of endogenous PA 
that is generated by PLD on PLA, activation. The result 
in Fig. 2A shows that addition of ethanol to [“H]AA- 
labeled mast cells suppressed dose-dependently 
A23187-induced AA liberation but the suppression was 
up to approximately 50% at the concentration of 2% 
ethanol. To the contrary, when the mast cells had been 
24 
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treated with propranolol, an inhibitor of PA 
phosphohydrolase, to accumulate PLD-derived PA, 
[3H]AA liberation gradually increased dose-depen- 
dently. Under the condition t3H]PA formation was ob- 
served to increase significantly and at 200 PM of pro- 
pranolol it reached approximately twice that in the 
absence of propranolol, as indicated in Fig. 2B. We 
examined the effect of p-bromophenacyl bromide to 
inhibit PLA, activity on AA liberation that is independ- 
ent on ethanol treatment. As shown in Fig. 3, ethanol 
suppressed AA liberation to about half level of the con- 
trol 10 min after stimulation. However, when the cells 
had been pretreated with p-bromophenacyl bromide, 
the AA liberation in the presence of ethanol was com- 
pletely inhibited. Under the condition, it is confirmed 
that ethanol completely inhibited the PA accumulation 
in any time of incubation examined (data not shown). 
4. DISCUSSION 
In our previous work we reported that exogenous PA 
could activate PLA, as well as PLC in platelets [22]. In 
the present work, we confirmed that didecanoyl PA, 
when added exogenously in the presence of Ca”, dose- 
dependently induced AA liberation that was inhibited 
by p-bromophenacyl bromide (Fig. 1). This indicates 
that the PA is involved in control of PLA, activation in 
mast cells. 
The activation of PLD is detected by the formation 
of phosphatidylethanol under stimulation with agonists 
in the presence of ethanol, due to a PLD-catalyzed 
transphosphatidylation reaction [35]. Our results 
showed that A23187-induced PA formation was mark- 
edly diminished with concomitant increase in phosphat- 
idylethanol as ethanol concentration increases, and in 
the presence of 2% ethanol no PA accumulation was 
observed (Fig. 2A). Furthermore, propranolol. an in- 
hibitor of PA phosphohydrolase, elevated A23 187-in- 
duced PA formation dose-dependently (Fig. 2B). These 
results clearly indicate that most of the PA is formed by 
endogenous PLD-catalyzed hydrolytic action on mem- 
brane phospholipids, presumably phosphatidylcholine, 
and therefore PLC/DAG kinase pathway may not be 
involved in the PA formation under the condition used. 
On the other hand, A23187-induced AA liberation 
was decreased by ethanol treatment dose-dependently 
but the decrease was up to 50% even in the presence of 
2% ethanol which inhibited completely the PA forma- 
tion (Fig. 2A). Therefore, the amount of AA released 
that was inhibited by ethanol might possibly be derived 
by lipase action on DAG that arises from PA through 
the action of PA phosphohydrolase. However, the treat- 
ment with propranolol to inhibit the conversion of PA 
to DAG did not decrease, but rather enhanced the AA 
liberation (Fig. 2B). This evidence suggests the possibil- 
ity that the PA, accumulated by preventing the conver- 
sion, might potentiate the PLA, activity, resulting in 
0- 
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Fig. 3. Effect of ethanol and p-bromophenacyl bromide on time- 
dependent AA liberation in response to A23187. [3H]AA-labeled mast 
cells were treated with 2% ethanol m the absence (A) or presence of 
10 PM p-bromophenacyl bromide (A), or buffer b:s) at 37°C for 10 
min. and stimulated with 30 nM A23187 in the presence of 1.3 mM 
CaClz for the period of time indicated. The radioactivity of [‘H]AA 
was determined. Each point represents mean S.E.M. of three sepa- 
rate experiments. 
further AA liberation. Consequently, it is reasonable to 
consider that the ethanol-sensitive AA liberation upon 
stimulation with A23187 is evoked by both the potenti- 
ated PLA, action by PA generated through PLD and 
DAG lipase action on DAG derived from the PA. The 
AA liberation that was not inhibited by ethanol (ap- 
proximately 50% of the total liberation) was almost 
completely inhibited by further treatment with p-bro- 
mophenacyl bromide (Fig. 3) suggesting that the liber- 
ation arised from the hydrolytic action of PLA, on 
membrane phospholipids. 
Recently, it was reported that three distinct PLA, 
species, 14-kDa group II PLAZ, 85-kDa cytosolic PLA, 
and PLAz having substrate specificity for phosphati- 
dylserine, were detected in rat mastocytoma RBL-2H3 
cells and bone marrow-derived mast cells [36]. Although 
it is unknown yet whether or not rat peritoneal mast 
cells have all of these three PLA, species, it is suggested 
that prostaglandin Dz generation on IgE-mediated acti- 
vation of the cells might be mediated by 85kDa cy- 
tosolic PLA2, not by 16kDa group II PLA, [37]. In our 
recent publication we have shown that the activity of 
partially purified 85-kDa cytosolic PLA, from rabbit 
platelets which exhibits specificity for arachidonoyl res- 
idue ofphospholipids, is significantly potentiated by PA 
[22]. These observations lead to the suggestion that the 
activation of 85-kDa cytosolic PLA, might be involved 
in the endogenous PA-enhanced AA liberation found in 
the present work. 
The mechanism by which endogenously generated 
PA potentiates PLAz activation is not yet clear. The 
possibility exists that the accumulated PA in mem- 
25 
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branes may increase the affinity of the membrane to 
associate with the enzyme or calcium, due to the anionic 
charge of PA, leading to enhancement of the enzyme 
activity [38]. Another mechanism may be that PA may 
act via its specific receptor-mediated process, although 
existence of the PA receptor has been reported so far 
only on 3T3 fibroblasts by Nakamura and Ui [5]. 
In conclusion, we suggest that while the PA formed 
by PLD action is converted to DAG that is hydrolyzed 
by DAG lipase to liberate free AA, it has a role for 
potentiating PLA, action to contribute to further AA 
formation upon stimulation of mast cells with A23 187. 
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